跳至主要内容
临床试验/NCT04320459
NCT04320459已完成不适用

Alexithymia in Ankylosing Spondylitis

Istanbul Medeniyet University1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2016年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
110
试验地点
1
主要终点
Alexithymia rate in AS patients and controls according to Toronto Alexithymia Scale-20

研究概览

简要总结

The study included 55 patients having Ankylosing Spondylitis (AS) for at least 1 year diagnosed according to the ASAS classification criteria who presented to our hospital's outpatient clinic and 55 healthy subjects. Demographic data were recorded for 55 AS patients who were subsequently assessed using the BASMI (Bath Ankylosing Spondylitis Metrology Index) in terms of elasticity and spinal mobility as well as the BASFI (Bath Ankylosing Spondylitis Functional Index) to determine functional status, the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) to assess the disease activity and the ASQoL (Ankylosing Spondylitis Quality of Life Questionnaire) to evaluate quality of life. The Toronto Alexithymia Scale-20 (TAS-20) was used for assessment of alexithymia and Beck's Depression Inventory (BDI) for depression among patients.

详细描述

The study included 55 patients having Ankylosing Spondylitis (AS) for at least 1 year diagnosed according to the ASAS classification criteria who presented to our hospital's outpatient clinic and 55 healthy subjects. Demographic data were recorded for 55 AS patients who were subsequently assessed using the BASMI (Bath Ankylosing Spondylitis Metrology Index) in terms of elasticity and spinal mobility as well as the BASFI (Bath Ankylosing Spondylitis Functional Index) to determine functional status, the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) to assess the disease activity and the ASQoL (Ankylosing Spondylitis Quality of Life Questionnaire) to evaluate quality of life. The Toronto Alexithymia Scale-20 (TAS-20) was used for assessment of alexithymia and Beck's Depression Inventory (BDI) for depression among patients.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed as AS for at least 1 year according to the ASAS classification criteria
  • over 18 years old

排除标准

  • fibromyalgia
  • age less than 18 years
  • vision and hearing impairment
  • neurological disease (Parkinson's disease, multiple sclerosis, cerebrovascular disease),
  • history of a psychiatric disorder (schizophrenia, bipolar disorder)
  • history of chronic condition (DM, thyroid disease) or malignancy

结局指标

主要结局

Alexithymia rate in AS patients and controls according to Toronto Alexithymia Scale-20

时间窗: 7 months

Depression rate in AS patients and controls according to Beck Depression Inventory

时间窗: 7 months

Relationship between alexithymia and depression and functional indexes (BASFI, BASMI, BASDAI, ASQoL)

时间窗: 7 months

次要结局

未报告次要终点

研究者

发起方
Istanbul Medeniyet University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Bilinç Doğruöz Karatekin

MD, Research Assistant of PMR

Istanbul Medeniyet University

研究点 (1)

Loading locations...

相似试验